March 2019
Price: £95 PLUS VAT
Format: DOWNLOADABLE PDF
This conference was a timely opportunity to discuss the next steps for health research in England - looking at funding, regulation and policy.
Sessions considered priorities for utilising Government funding for NHS health research in light of the publication of NHS England’s Long Term Plan, which looks at prevention, earlier diagnosis, the role of genomics and the impact of research and development on the UK economy.
The conference followed the release of the second Life Sciences Sector Deal - which looks to strengthen the role of the life sciences sector in transforming the prevention, diagnosis and treatment of chronic diseases - as well as the key issues for collaboration and the regulation of clinical trials following Brexit.
Delegates assessed the way forward for improving collaboration on innovation and sharing data - with the new Life Sciences Sector Deal citing over £1.3bn in investment from the private sector.
Further sessions focused on additional opportunities for supporting public and patient involvement in healthcare research as Government and industry aim to study 5m healthy people to develop new diagnostic tests and improve detection of deadly diseases.
